Martins, Adelino
Herzog, Sereina A.
Mugenyi, Levicatus
Faes, Christel
Hens, Niel
Abrams, Steven
Funding for this research was provided by:
European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme (682540 – TransMID)
Special Research Fund at Hasselt University (BILA R-8133)
Article History
Received: 17 April 2022
Accepted: 14 November 2022
First Online: 10 December 2022
Declarations
:
: All children aged 0.5–10 years who fulfilled the selection criteria and had written informed consent from a parent or guardian from each household were enrolled into the PRISM cohorts in Phase I. The PRISM project was approved by the Uganda National Council for Science and Technology (HS 1019 for Phase 1), Makerere University School of Medicine Research and Ethics Committee (2011-167 for Phase 1), the University of California, San Francisco Committee on Human Research (11-05995 for Phase 1).
: Not applicable.
: The authors declare that they have no competing interests.